Carboplatin

ClinicalAugust 22, 2026

AbbVie initiates trial for Mirvetuximab Soravtansine in Ovarian Cancer with multiple treatment combinations

AbbVie has initiated a clinical trial to assess the safety and efficacy of Mirvetuximab Soravtansine in combination with carboplatin and bevacizumab for the treatment of ovarian cancer.

ClinicalAugust 19, 2026

Phase 2 Trial of Datopotamab Deruxtecan in NSCLC with Brain Metastases Initiated

A Phase II, single-arm trial is underway evaluating Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab in treatment-naive patients with brain metastases from non-small cell lung cancer.

Clinical

Sponsor company

Recent signals(4)

AbbVie initiates trial for Mirvetuximab Soravtansine in Ovarian Cancer with multiple treatment combinations

Phase 2 Trial of Datopotamab Deruxtecan in NSCLC with Brain Metastases Initiated

Phase II Trial of Carboplatin in Metastatic Prostate Cancer with HR Pathway Alterations

SonoCloud-9 Enhances Carboplatin Delivery in Recurrent Glioblastoma Trial

Upcoming milestones

Related catalysts

Indications

Therapeutic areas

Get signals before the market moves